Katell Le Du

8PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedDisease surveillanceRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

|Apr 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Sep 26, 2025
Multiple brain lesions in a patient with relapsed hairy cell leukemia: a case report and review of the literature.

Katell Le Dû, Jacques Delaunay, Maud Voldoire

|May 06, 2025
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).

Katell Le Dû, Adrien Chauchet, Sophie Sadot-Lebouvier

|Feb 15, 2023
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.

Katell Le Du, Anne-Lise Septans, Frédéric Maloisel

|Nov 25, 2022
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.

Jonas Dubu, Sébastien Boyas, Virginie Roland

Pageof 2

Frequent Collaborators

3 joint publications

Cédric Rossi

3 joint publications

David Tonnelet

3 joint publications

Eric Durot

3 joint publications

Ghandi Damaj